Quotables
"That the automobile has practically reached the limit of its development is suggested by the fact that during the past year no improvements of a radical nature have been introduced."
Scientific American ; Jan. 2 edition, 1909
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8101762 | Nitrogen-containing organic compounds usable as catalytic composition precursors The present invention describes novel nitrogen-containing organic compounds obtained by reacting a compound X of substituted pyridine type comprising at least one ketone function with a compound Y belonging to the aminoquinoleine family and derivatives thereof. Said... | 01/24/2012 |
| 7396399 | Bipyridine-based metal complex and ink composition comprising the same A bipyridine-based metal complex includes a complex of bipyridine-based ligands and metals, and is utilized in an ink composition. The bipyridine-based metal complex may be used alone, as well as in combination with other coloring agents. ... | 07/08/2008 |
| 7361796 | Orangic electroluminescence device A compound having a diphenylanthracene structure at the center and a specific structure substituted with an aryl group at end portions. An organic electroluminescence device comprises a plurality of layers of thin films of organic compounds which comprise a light em... | 04/22/2008 |
| 7355775 | Photochromic diarylethene-containing coordination compounds and the production thereof Diarylethene-containing ligands and their coordination compounds are described. The ligands display photochromism with UV excitation, while the coordination compounds display photochromism with both excitation in the UV region and excitation into lower energy absorp... | 04/08/2008 |
| 7282586 | Dipyridine-based compound and the use thereof The present invention discloses a dipyridine-based compound which can be used as electron-transporting and/or hole blocking material or phosphorous host in organic electroluminescence devices is disclosed. The mentioned dipyridine-based compound is represented by th... | 10/16/2007 |
| 7247641 | Compounds, derivatives, compositions, preparation and uses This invention relates to compounds, pharmaceutical compositions, and methods of using the disclosed compounds for inhibiting PARP. ... | 07/24/2007 |
| 7119204 | Charge transport compositions and electronic devices made with such compounds The present invention relates to charge transport compositions. The invention further relates to electronic devices in which there is at least one active layer comprising such charge transport compositions. ... | 10/10/2006 |
| 7097354 | Method of determining the temperature in a system comprising a molecular heater fraction and a molecular thermometer fraction The present invention is related to a method of determining the temperature in a system, said system comprising a molecular heater fraction and a molecular thermometer fraction, and to an integrated system for temperature determination and temporally and spatially r... | 08/29/2006 |
| 7091351 | Vanadium compounds for treating cancer The invention provides methods for treating cancer and compounds that are useful for the treatment of tumors, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates useful for preparing the compounds. ... | 08/15/2006 |
| 6979681 | Half-sandwich ruthenium (II) compounds comprising nitrogen containing ligands for treatment of cancer Ruthenium (II) compounds of the formula: wherein: R1 is —CO2CH3; R2, R3, R4, R5 and R6 independently represent H, alkyl, cylcoal... | 12/27/2005 |
| 6972334 | Bathophenathroline compound and process for preparing same A novel bathophenanthroline compound of the general formula [I] or [II] is provided wherein R1 and R2 may be the same or different and independently represent a linear, branched or cyclic, saturate... | 12/06/2005 |
| 6962995 | Charge transport compositions and electronic devices made with such compositions The present invention relates to charge transport compositions. The invention further relates to electronic devices in which there is at least one active layer comprising such charge transport compositions. ... | 11/08/2005 |
| 6951863 | Pyridoarylphenly oxazolidinone antibacterials, and related compositions and methods Pyridoarylphenyl oxazolidinone compounds of the formula: in which the substituents have the meaning indicated in the description. These compounds are useful as antibacterial agents. ... | 10/04/2005 |
| 6936622 | 6-phenylbenzonaphthyridines Compounds of the formula (I), in which R1, R2, R3, R4 and R5 have the meanings indicated in the description, are novel effective PDE3/4 Inhibitors. ... | 08/30/2005 |
| 6936634 | Ruthenium (II) compounds for use in the therapy of cancer Compounds which may be used in the treatment and/or prevention of cancer have the formula (I): wherein R1 and R2 together with the ring to which they are bound represent a saturated or unsaturated carbocyclic or heterocyclic group ... | 08/30/2005 |
| 6921768 | Cytostatic cerium compounds The invention relates to cerium compounds having general formulas (I) Rni+Yin− and (II) Rb+Yb+ and their application as medicaments in the prophylaxis and/or treatment of cance... | 07/26/2005 |
| 6808939 | ECL labels having improved non-specific binding properties, methods of using and kits containing the same Bipyridine or phenanthroline ligands presenting functional groups that prevent non-specific binding (in particular, negatively charged functional groups that are unaffected by standard conditions for conjugating biological reagents through amide bonds) are described... | 10/26/2004 |
| 6743786 | Vanadium compounds for treating cancer The invention provides methods for treating cancer and compounds that are useful for the treatment of tumors, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates useful for preparing the compounds. ... | 06/01/2004 |
| 6730788 | Process for 1,10-phenanthroline ligands Process for preparing 1,10-phenanthroline ligands represented by the formula which comprises coupling a 1,10-phenanthroline of the formula with a ketone e.g. a dialkyl, cyclo... | 05/04/2004 |
| 6706879 | Fluorescent dye The invention relates to fluorescent dyes. More particularly, the invention relates to fluorescent cyanine dyes, and especially to water soluble fluorescent cyanine dyes that contain additional sites for attachment to biomolecules. The invention provides a group of ... | 03/16/2004 |
| 6667313 | 8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor modulators Non-steroidal compounds and compositions which are agonists, partial agonists, and antagonists for androgen receptors and methods of preparation for the non-steroidal compounds and compositions.... | 12/23/2003 |
| 6583150 | Pharmaceutical composition based on polyaromatic compounds A pharmaceutical composition comprising an efficient amount of a compound selected among the compounds of formulae (I) and (II). The compounds have useful cytotoxic properties providing therapeutic application as antitumoral medicine.... | 06/24/2003 |
| 6566362 | Benzo[f]naphthyridine derivatives, their preparation and compositions containing them Benzo[f]naphthyridine derivatives of formula (I): ##STR1## benzo[f]naphthyridine derivatives and benzo[f]naphthyridine esters of formula (IVa): ##STR2## aminoquinoline derivatives of formula (X): ##STR3## processes for preparing such compounds; and c... | 05/20/2003 |
| 6531632 | Bis-o-aminophenols and o-aminophenolcarboxylic acids and process for preparing the same Bis-o-aminophenols and o-aminophenolcarboxylic acids have the following structures: ##STR1## A1 to A7 are, independently of each other, H, F, CH3, CF3, OCH3 or OCF3. T is an aromatic or het... | 03/11/2003 |
| 6503922 | Bridged nicotine compounds for use in the treatment of CNS pathologies Pharmaceutical compounds comprising bridged nicotine analogs of N-octylnicotinium iodide (NONI) having selective antagonist properties at 댓댢-containing nicotinic receptor subtypes, and compositions containing these compounds. The compounds a... | 01/07/2003 |
| 6432941 | Vanadium compounds for treating cancer The invention provides methods for treating cancer and vanadium compounds that are useful for the treatment of tumors, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates useful for preparing the compou... | 08/13/2002 |
| 6433174 | Process for producing novel naphthyridine derivatives A novel naphthyridine derivative showing high activity as a tachykinin receptor antagonist can be produced at high efficiency by reacting an acylating agent such as a carboxylic acid derivative with a compound represented by the formula (1): ##STR1##... | 08/13/2002 |
| 6200974 | Phenanthroline derivatives The present invention provides a phenanthroline derivative of formula (I) ##STR1## wherein, for example, R1 is hydrogen, carboxy, cyano, nitro, (1-4C)alkyl, (1-6C)alkoxycarbonyl, (1-4C)alkylamino, (2-4C)alkanoyl, (1-4C)alkoxy-(2-4C)alkoxy-(2-4C... | 03/13/2001 |
| 6197782 | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses Disclosed are nitrosated and/or nitrosylated phosphodiesterase inhibitors having the formula NOn -PDE inhibitor where n is 1 or 2. The invention also provides compositions comprising such compounds in a pharmaceutically acceptable carrier. The ... | 03/06/2001 |
| 6168838 | Fluorinated phenantrene derivatives for liquid crystal mixtures Fluorinated phenanthrene derivatives and their use in liquid-crystalline mixtures Fluorinated phenanthrene derivatives of the formula (I) ##STR1## in which G is --CHF--CH2 -- or --CF.dbd.CH--, E1, E2, E3, E4 | 01/02/2001 |
| 6031098 | Detection and treatment of duplex polynucleotide damage Duplex polynucleotides containing damage or errors are detected with hindered intercalating compounds which are capable of intercalating only in the presence of such damage or error. Conditions characterized by the presence of polynucleotide errors or dam... | 02/29/2000 |
| 5916898 | Phenanthroline derivatives The present invention provides a phenanthroline derivative of formula (I) ##STR1## wherein, for example, R1 is hydrogen, carboxy, cyano, nitro, (1-4C)alkyl, (1-6C)alkoxycarbonyl, (1-4C)alkylamino, (2-4C)alkanoyl, (1-4C)alkoxy-(2-4C)alkoxy-... | 06/29/1999 |
| 5866587 | Metalloprotease inhibitors Compound of formula (I): ##STR1## in which: m, n, which are identical or different, represent 0, 1 or 2, R1, R2, which are identical or different, represent hydrogen, optionally substituted alkyl, aryl, or form with the carbon atom c... | 02/02/1999 |
| 5858650 | Methods for inactivating nucleotide sequences and metal chelates for use therein This invention relates to methods, reagents, and kits utilizing metal chelates to inactivate nucleotide sequences, especially to inactivate polymerase chain reaction (PCR) and ligase chain reaction (LCR) products and to inactivate nucleotide sequences in ... | 01/12/1999 |
| 5856334 | Imidazoquinoline derivatives Specified imidazoquinoline derivatives represented by the formula (I): ##STR1## where Q represents an optionally substituted phenyl, pyridyl or furyl group; Y represents either a hydrogen atom or, when taken together with Z, an oxygen atom and a meth... | 01/05/1999 |
| 5648362 | Fluoroalkylated amphiphilic ligands, their metallic complexes and their uses Fluoroalkylated amphiphilic ligands are derived from aromatic amines of the bipyridine (I) or phenanthroline (II) types, and form complexes with platinum, palladium and ruthenium. ##STR1## In formulae (I) and (II), R1 and R2 are... | 07/15/1997 |
| 5646284 | Polarizable phenanthroline complex crystal having improved stability to heat and moisture A complex crystal is composed of anion of triiodine and cation of a fused compound consisting essentially of at least one nitrogen atom and at least 3 aromatic fused rings. Since the complex crystal has such a stable structure, it shows excellent heat res... | 07/08/1997 |
| 5602142 | DNA-affinic hypoxia selective cytotoxins Hypoxia selective cytotoxins having the structural formula ##STR1## wherein D, E, F and G, independently, are carbon or nitrogen, with the proviso that three or more of D, E, F and G are carbon; R1 and R2, independently, are sel... | 02/11/1997 |
| 5576326 | Copper amino acidate diimine nitrate compounds and their methyl derivatives and a process for preparing them Copper amino acidate diimine nitrate compounds of the formula [Cu(N--N)(N--O)]+NO3.sup.-, where (N--N) is a diimine selected from 1,10-phenanthroline or 4,7-dimethyl 1,10-phenanthroline and (N--O) is tyrosine-alaninate, threoninate, ... | 11/19/1996 |
| 5567710 | Polycyclic fused ring modulators of acetylcholine receptors In accordance with the present invention, there is provided a class of polycyclic fused ring compounds which are modulators of acetylcholine receptors. The compounds of the invention displace acetylcholine receptor ligands from their binding sites. Invent... | 10/22/1996 |
